Randomized, Double-blind Study of Efficacy and Safety of Bexotegrast (PLN-74809) for Idiopathic Pulmonary Fibrosis

NCT06097260 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

320

Enrollment

INDUSTRY

Sponsor class

Stopped DSMB recommendation

Conditions

Idiopathic Pulmonary Fibrosis

Interventions

DRUG: PLN-74809
DRUG: Placebo

Sponsor

Pliant Therapeutics, Inc.